利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

15 条记录 (耗时 0.053 秒)

    Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal application
    2.
    发明授权
    Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal application 失效
    吲哚衍生物制备方法，含有它们的药物组合物及其药物应用

    公开(公告)号：US06706750B1

    公开(公告)日：2004-03-16

    申请号：US10009568

    申请日：2002-03-11

    申请人： Jonathan Mark Bentley ,  Jonathan Richard Anthony Roffey ,  James Edward Paul Davidson ,  Howard Langham Mansell ,  Richard John Hamlyn ,  Ian Anthony Cliffe ,  David Reginald Adams ,  Nathaniel Julius Monck

    发明人： Jonathan Mark Bentley ,  Jonathan Richard Anthony Roffey ,  James Edward Paul Davidson ,  Howard Langham Mansell ,  Richard John Hamlyn ,  Ian Anthony Cliffe ,  David Reginald Adams ,  Nathaniel Julius Monck

    IPC分类号： A61K3140

    CPC分类号： C07D495/04 ,  C07D209/94

    摘要： A chemical compound of formula (I) wherein: R1 and R2 are independently selected from hydrogen and alkyl; R3 is alkyl; R4, R6 and R7 are independently selected from hydrogen, halogen, hydroxy, alkyl, aryl, amino, alkylamino, dialkylamino, alkoxy, aryloxy, alkylthio, alkylsufoxyl, alkylsulfonyl, nitro, carbonitrile, carbo-alkoxy, carbo-aryloxy and carboxyl; R5 is selected from hydrogen, halogen, hydroxy, alkyl, aryl, amino, alkylamino, dialkylamino, alkoxy, aryloxy, alkylthio, alkylsulfoxyl, alkylsulfonyl, nitro, carbonitrile, carbo-alkoxy, carbo-aryloxy and carboxyl; A is a 5- or 6-membered partially unsaturated or aromatic heterocyclic ring or a 5- or 6-membered partially unsaturated carbocyclic ring, wherein if A is a 6-membered partially unsaturated carbocyclic ring then at least one of R4 to R7 is other than hydrogen, and pharmaceutically acceptable salts, addition compounds and prodrugs thereof, and the use thereof in therapy, particularly as an agonist or antagonist of a 5HT receptor, particularly a 5HT2C receptor, for instance in the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinial disorders; diabetes insipidus, and sleep apnea, and particularly for the treatment of obesity.

    摘要翻译： 式（I）的化合物，其中：R 1和R 2独立地选自氢和烷基; R3是烷基; R4，R6和R7独立地选自氢，卤素，羟基，烷基，芳基，氨基，烷基氨基，二烷基氨基，烷氧基，芳氧基，烷硫基，烷基磺酰基，烷基磺酰基，硝基，腈，碳 - 烷氧基，碳 - 芳氧基和羧基; R5选自氢，卤素，羟基，烷基，芳基，氨基，烷基氨基，二烷基氨基，烷氧基，芳氧基，烷硫基，烷基亚磺酰基，烷基磺酰基，硝基，腈，碳 - 烷氧基，碳 - 芳氧基和羧基; A是5或6元部分不饱和或芳族杂环或5或6元部分不饱和碳环，其中如果A是6元部分不饱和的碳环，则R 4至R 7中的至少一个 >不是氢，和其药学上可接受的盐，加成化合物和前药，以及其在治疗中的用途，特别是作为5HT受体，特别是5HT 2C受体的激动剂或拮抗剂，例如用于治疗中枢性疾病 神经系统; 损害中枢神经系统; 心血管疾病; 胃肠疾病; 尿崩症和睡眠呼吸暂停，特别是用于治疗肥胖。

    Indazole derivatives with 5-HT2 receptor activity
    7.
    发明授权
    Indazole derivatives with 5-HT2 receptor activity 失效
    具有5-HT2受体活性的吲唑衍生物

    公开(公告)号：US06552062B1

    公开(公告)日：2003-04-22

    申请号：US09763886

    申请日：2001-02-28

    申请人： David Reginald Adams ,  Jonathan Mark Bentley ,  Jonathan Richard Anthony Roffey ,  Richard John Hamlyn ,  Ashley Roger George

    发明人： David Reginald Adams ,  Jonathan Mark Bentley ,  Jonathan Richard Anthony Roffey ,  Richard John Hamlyn ,  Ashley Roger George

    IPC分类号： A61K31416

    CPC分类号： C07D231/56

    摘要： A chemical compound of formula (I) wherein R1 to R3 are independently selected from hydrogen and alkyl; R4 to R7 are independently selected from hydrogen, halogen, hydroxy, alkyl, aryl, amino, monoalkylamino, dialkylamino, alkoxy, aryloxy, alkylthio, arylthio, arylsulfoxyl, arylsulfonyl, alkylsulfoxyl, alkylsulfonyl, nitro, cyano, carboxaldehyde, alkylcarbonyl, arylcarbonyl, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonylamino, aminocarbonyloxy, monoalkylaminocarbonyloxy, dialkylaminocarbonyloxy, monoalkylaminocarbonylamino and dialkylaminocarbonylamino; and R8 is selected from alkyl and alkoxy, and pharmaceutically acceptable salts and prodrugs thereof, and the use thereof in therapy, particularly for the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea, and particularly for the treatment of obesity.

    摘要翻译： 式（I）的化合物，其中R 1至R 3独立地选自氢和烷基; R4至R7独立地选自氢，卤素，羟基，烷基，芳基，氨基，单烷基氨基，二烷基氨基，烷氧基，芳氧基，烷硫基，芳硫基，芳基亚砜基，芳基磺酰基，烷基亚砜基，烷基磺酰基，硝基，氰基，甲醛，烷基羰基，芳基羰基，氨基羰基 单烷基氨基羰基，二烷基氨基羰基，烷氧基羰基氨基，氨基羰基氧基，单烷基氨基羰基氧基，二烷基氨基羰基氧基，单烷基氨基羰基氨基和二烷基氨基羰基氨基; 并且R 8选自烷基和烷氧基及其药学上可接受的盐和前药，及其在治疗中的用途，特别是用于治疗中枢神经系统疾病的用途; 损害中枢神经系统; 心血管疾病; 胃肠道疾病; 尿崩症和睡眠呼吸暂停，特别是用于治疗肥胖。